Federal Register · Regulatory notice
Potential Designation of Passage of an Accredited Investor Exam To Be Developed by FINRA as Qualifying Natural Persons for Accredited Investor Status
Notice is given that the Securities and Exchange Commission (the "Commission") is considering whether to issue an order designating passage of an accredited investor exam (the "Exam") to be developed by the Financial Industry Regulatory Authority, Inc. ("FINRA") as qualifying natural persons for accredited investor status.
Follow NDAQ- Became public
- Oct 5, 2026
- Event / period date
- Not stated
- Collected
- Nov 8, 2026, 8:48 AM EST
Why this is connected
The source explicitly mentions NASDAQ, INC.. A mention alone does not establish a financial benefit.
Source evidence
Read the source excerpt or record
is as part of the test would be sufficient to determine level of understanding''); letter from the Maryland State Bar Association (Mar. 16, 2020) (noting that ``[w]ith respect to persons who believe that they have the requisite sophistication, knowledge, and experience such that they should qualify as accredited investors, we believe that an accredited investor examination to determine investor sophistication . . . would be a much better way to address this issue''); letter from Carta, Inc. (Mar. 16, 2020) (``Carta''); letter from David R. Burton (May 1, 2020) (``D. Burton''). The comment letters to the Accredited Investor Proposing Release are available at https://www.sec.gov/comments/s7-25-19/s72519.htm . \24\ Letter from Carta. See also letter from D. Burton (``Ordinary people outside of the financial industry should have a means to prove that they have the knowledge and sophistication to qualify. Such a test would be central to democratizing access to Regulation D investments and enabling people who have developed the requisite knowledge to have access to these investments.''). \25\ See letter from Einar Vollset (Dec. 18, 2019) (stating that ``[r]equiring highly expensive and specialized professional certifications such as Series 7, 65 or 82 is completely pointless exercise'' and proposing ``a basic exam proving an understanding of the risks involved'' and opposing the Seri
Congressional trading in NDAQ
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Sep 9, 2026$100K–$250K
Rep. April McClain Delaney (D-MD-6)
$100K–$250K · Traded Aug 25, 2026 · disclosed Sep 9, 2026 · Dependent
- Jul 21, 2026$50K–$100K
Sen. Alan Armstrong (R-OK)
$50K–$100K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
- May 11, 2026$1K–$15K
- May 11, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Apr 13, 2026 · disclosed May 11, 2026 · Spouse
- May 6, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Apr 24, 2026 · disclosed May 6, 2026 · Dependent
- Apr 6, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Mar 31, 2026 · disclosed Apr 6, 2026 · Dependent
- Apr 6, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Mar 18, 2026 · disclosed Apr 6, 2026 · Dependent
- Apr 6, 2026$1K–$15K
Rep. April McClain Delaney (D-MD-6)
$1K–$15K · Traded Mar 10, 2026 · disclosed Apr 6, 2026 · Dependent
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.